LALPATHLAB2024-01-012024-03-31 LALPATHLAB2024-01-012024-03-31 LALPATHLAB2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member LALPATHLAB2024-01-012024-03-31in-bse-fin:OneOperatingExpenses02Member LALPATHLAB2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member LALPATHLAB2024-01-012024-03-31in-bse-fin:FourOperatingExpenses02Member LALPATHLAB2024-03-31 LALPATHLAB2024-01-012024-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member LALPATHLAB2024-01-012024-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member LALPATHLAB2024-01-012024-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member LALPATHLAB2024-01-012024-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 539524 LALPATHLAB NOTLISTED Dr. Lal Path Labs Ltd. Equity 2023-04-01 2024-03-31 2024-05-10 2024-05-03 INR Millions Yearly 11:15:00 13:35:00 2024-05-10 2024-05-10 true Cash Flow Indirect Declaration of unmodified opinion Single segment The business of running laboratories for carrying out Pathological investigations of various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations. 2024-01-01 2024-03-31 Unaudited Consolidated 5454000000.00 184000000.00 5638000000.00 1089000000.00 0.00 0.00 1054000000.00 66000000.00 366000000.00 1864000000.00 4439000000.00 1199000000.00 0.00 1199000000.00 326000000.00 15000000.00 341000000.00 0.00 858000000.00 0.00 0.00 0.00 0.00 858000000.00 -9000000.00 849000000.00 845000000.00 13000000.00 837000000.00 12000000.00 835000000.00 10 10.13 10.12 0.00 0.00 10.13 10.12 i. The above consolidated results were reviewed by the Audit Committee and approved by the Board of Directors in their respective meetings held on 10 May, 2024 respectively. The consolidated financial results for the year ended 31 March, 2024 have been audited and for the quarter ended 31 March, 2024 have been reviewed by the statutory auditors of the Company and they have issued an unmodified report thereon. ii. The above consolidated results represent consolidated results of the Company and its subsidiaries (together referred to as the Group'). iii. These financial results of the Group have been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and in terms of regulation 33 the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended and other accounting principles generally accepted in India. iv. Figures for the quarter ended 31 March, 2024 and 31 March, 2023 are the balancing figures between the audited figures in respect of full financial year and the published year to date unaudited figures up to the third quarter ended 31 December, 2023 and 31 December, 2022 respectively, which was subjected to limited review. Due to size constraint, we have not pasted complete note of financial results. Please refer pdf file for complete notes to the Financial Results for the quarter and financial year ended March 31, 2024. Single segment 2023-04-01 2024-03-31 Audited Consolidated 22266000000.00 692000000.00 22958000000.00 4514000000.00 0.00 0.00 4245000000.00 294000000.00 1436000000.00 7414000000.00 17903000000.00 5055000000.00 0.00 5055000000.00 1480000000.00 -48000000.00 1432000000.00 0.00 3623000000.00 0.00 0.00 0.00 0.00 3623000000.00 -6000000.00 3617000000.00 3577000000.00 46000000.00 3572000000.00 45000000.00 835000000.00 10 17658000000.00 43.05 42.98 0.00 0.00 43.05 42.98 Fees to collection centers/channel partners 756000000.00 Other expenses 1108000000.00 Fees to collection centers/channel partners 3130000000.00 Other expenses 4284000000.00 361000000.00 3430000000.00 40000000.00 337000000.00 5482000000.00 3026000000.00 17000000.00 0.00 0.00 0.00 0.00 0.00 317000000.00 317000000.00 449000000.00 195000000.00 13293000000.00 373000000.00 1138000000.00 774000000.00 3609000000.00 4694000000.00 13000000.00 470000000.00 10698000000.00 0.00 196000000.00 11267000000.00 0.00 0.00 24560000000.00 835000000.00 17658000000.00 18493000000.00 18854000000.00 0.00 0.00 1030000000.00 1030000000.00 0.00 24000000.00 0.00 0.00 1054000000.00 833000000.00 1866000000.00 1093000000.00 3792000000.00 348000000.00 379000000.00 133000000.00 0.00 4652000000.00 0.00 0.00 5706000000.00 24560000000.00 294000000.00 -35000000.00 -73000000.00 0.00 -39000000.00 0.00 0.00 18000000.00 0.00 305000000.00 0.00 33000000.00 0.00 1436000000.00 0.00 87000000.00 0.00 61000000.00 0.00 -2000000.00 0.00 554000000.00 217000000.00 -104000000.00 0.00 0.00 -20000000.00 -5000000.00 0.00 1619000000.00 6674000000.00 0.00 0.00 0.00 1320000000.00 0.00 5354000000.00 0.00 4000000.00 0.00 0.00 0.00 0.00 0.00 0.00 9000000.00 512000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 63000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 453000000.00 0.00 -126000000.00 0.00 -243000000.00 0.00 0.00 0.00 0.00 0.00 0.00 35000000.00 0.00 0.00 1533000000.00 0.00 335000000.00 2012000000.00 294000000.00 0.00 0.00 -4139000000.00 972000000.00 0.00 972000000.00 2637000000.00 3609000000.00 Remeasurement of the defined benefit obligations -13000000.00 Remeasurement of the defined benefit obligations -5000000.00 -13000000.00 -5000000.00 -3000000.00 -1000000.00 Exchange differences on translation of foreign operations 1000000.00 Exchange differences on translation of foreign operations -2000000.00 1000000.00 -2000000.00 0.00 0.00